Short Interest Buzzer: What’s in Aceto Corporation (NASDAQ:ACET) After Decline in Shorted Shares?

November 23, 2016 - By Hazel Jackson   ·   0 Comments

Short Interest Buzzer: What’s in Aceto Corporation (NASDAQ:ACET) After Decline in Shorted Shares?

The stock of Aceto Corporation (NASDAQ:ACET) registered a decrease of 5.71% in short interest. ACET’s total short interest was 2.04M shares in November as published by FINRA. Its down 5.71% from 2.16M shares, reported previously. With 136,500 shares average volume, it will take short sellers 15 days to cover their ACET’s short positions. The short interest to Aceto Corporation’s float is 7.12%. The stock closed at $19.53 during the last session. It is down 19.89% since April 21, 2016 and is downtrending. It has underperformed by 25.22% the S&P500.

Aceto Corporation is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The company has a market cap of $580.95 million. The Company’s business is organized along product lines into three divisions: Human Health, Pharmaceutical Ingredients and Performance Chemicals. It has a 19.41 P/E ratio. As of June 30, 2016, it distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the agricultural, coatings and industrial chemical industries.

Insitutional Activity: The institutional sentiment increased to 1.22 in 2016 Q2. Its up 0.36, from 0.86 in 2016Q1. The ratio improved, as 16 funds sold all Aceto Corporation shares owned while 49 reduced positions. 11 funds bought stakes while 45 increased positions. They now own 23.91 million shares or 7.56% less from 25.86 million shares in 2016Q1.
Invesco Limited accumulated 106,191 shares or 0% of the stock. The California-based Wells Fargo Mn has invested 0% in Aceto Corporation (NASDAQ:ACET). Northern Tru Corp last reported 0.01% of its portfolio in the stock. Motley Fool Wealth Management Ltd has 133,520 shares for 0.32% of their US portfolio. Blackrock Fund Advsrs, a California-based fund reported 1.92 million shares. Moreover, California State Teachers Retirement has 0% invested in Aceto Corporation (NASDAQ:ACET) for 61,107 shares. The New Jersey-based Systematic Mngmt Ltd Partnership has invested 0.02% in Aceto Corporation (NASDAQ:ACET). Moreover, Champlain Investment Prns Limited Liability Com has 0.31% invested in Aceto Corporation (NASDAQ:ACET) for 818,710 shares. Connors Investor Svcs, a Pennsylvania-based fund reported 72,621 shares. California Public Employees Retirement Sys owns 109,600 shares or 0% of their US portfolio. Hillcrest Asset Management Ltd Limited Liability Company accumulated 2.2% or 398,882 shares. Signaturefd Limited Com has 0% invested in the company for 315 shares. National Bank & Trust Of Montreal Can holds 68,055 shares or 0% of its portfolio. Ameriprise Fin, a Minnesota-based fund reported 256,815 shares. Moreover, Ny State Common Retirement Fund has 0% invested in Aceto Corporation (NASDAQ:ACET) for 88,520 shares.

Insider Transactions: Since May 26, 2016, the stock had 0 insider purchases, and 31 selling transactions for $3.14 million net activity. Srinivasan Satish sold $78,944 worth of stock. $154,110 worth of Aceto Corporation (NASDAQ:ACET) was sold by DEBENEDITTIS FRANK on Monday, June 6. Bartone Raymond also sold $53,605 worth of Aceto Corporation (NASDAQ:ACET) on Wednesday, July 6. Rogers Steven had sold 3,275 shares worth $73,681. NOETZLI HANS C also sold $109,906 worth of Aceto Corporation (NASDAQ:ACET) on Monday, November 14. On Tuesday, May 31 EILENDER ALBERT L sold $219,486 worth of the stock or 9,881 shares. GUCCIONE SALVATORE J SR also sold $5,106 worth of Aceto Corporation (NASDAQ:ACET) on Tuesday, September 6.

ACET Company Profile

Aceto Corporation (Aceto), incorporated on June 13, 1947, is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company’s business is organized along product lines into three divisions: Human Health, Pharmaceutical Ingredients and Performance Chemicals. As of June 30, 2016, the Company distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical industries. The Firm has presence in China, Germany, France, The Netherlands, Singapore, India, Hong Kong, Philippines, the United Kingdom and the United States.

More notable recent Aceto Corporation (NASDAQ:ACET) news were published by: Fool.com which released: “Why Shares of Aceto Corporation Plunged 23% Today” on August 26, 2016, also Streetinsider.com with their article: “ACETO Corp (ACET) Announces $412M Acquisition of Certain Assets from Citron …” published on November 03, 2016, Globenewswire.com published: “ACETO Corporation Schedules Fourth Quarter & Fiscal 2016 Financial Results …” on August 12, 2016. More interesting news about Aceto Corporation (NASDAQ:ACET) were released by: Globenewswire.com and their article: “ACETO Corporation Schedules First Quarter Fiscal 2017 Financial Results News …” published on October 21, 2016 as well as Globenewswire.com‘s news article titled: “ACETO Corporation Announces $125 Million Convertible Notes Offering” with publication date: November 09, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Hazel Jackson


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>